Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer-Reference-Cited by-同舟云学术

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

Published:2018-07-12 Issue:2 Volume:379 Page:122-137
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Francis Prudence A.¹,Pagani Olivia¹,Fleming Gini F.¹,Walley Barbara A.¹,Colleoni Marco¹,Láng István¹,Gómez Henry L.¹,Tondini Carlo¹,Ciruelos Eva¹,Burstein Harold J.¹,Bonnefoi Hervé R.¹,Bellet Meritxell¹,Martino Silvana¹,Geyer Charles E.¹,Goetz Matthew P.¹,Stearns Vered¹,Pinotti Graziella¹,Puglisi Fabio¹,Spazzapan Simon¹,Climent Miguel A.¹,Pavesi Lorenzo¹,Ruhstaller Thomas¹,Davidson Nancy E.¹,Coleman Robert¹,Debled Marc¹,Buchholz Stefan¹,Ingle James N.¹,Winer Eric P.¹,Maibach Rudolf¹,Rabaglio-Poretti Manuela¹,Ruepp Barbara¹,Di Leo Angelo¹,Coates Alan S.¹,Gelber Richard D.¹,Goldhirsch Aron¹,Regan Meredith M.¹

Affiliation:

1. From the Peter MacCallum Cancer Centre, St. Vincent’s Hospital, University of Melbourne, Melbourne, VIC, and Breast Cancer Trials Australia and New Zealand, University of Newcastle, Newcastle, NSW (P.A.F.), and the University of Sydney, Sydney (A.S.C.) — all in Australia; the Institute of Oncology of Southern Switzerland, Ospedale San Giovanni, Bellinzona (O.P.), Breast Cancer St. Gallen, St. Gallen (T.R.), and the International Breast Cancer Study Group Coordinating Center (R.M., M.R.-P., B.R., A.S.C.),...

Funder

Ipsen Fund

Pfizer

National Institutes of Health

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1803164

Cited by 476 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study;The Breast;2024-10

2. Neoadjuvant Chemotherapy with Concurrent Letrozole for Estrogen Receptor-Positive and HER2-Negative Breast Cancer: An Open-Label, Single-Center, Nonrandomized Phase II Study (NeoCHAI);Cancers;2024-09-10

3. Revisiting ovarian function suppression with GnRH agonists for premenopausal women with breast cancer: Who should use and the impact on survival outcomes;Cancer Treatment Reviews;2024-09

4. Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer;JAMA Oncology;2024-08-15

5. Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy;npj Breast Cancer;2024-08-01